Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Blood proteins or globulins – e.g. – proteoglycans – platelet...
Patent
1995-02-09
2000-02-15
Knode, Marian C.
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Blood proteins or globulins, e.g., proteoglycans, platelet...
5303873, 5303911, 435332, C07K 1618, C07K 1700, C12N 518
Patent
active
060254777
ABSTRACT:
This invention provides purified antigens which are indicative of the presence of atherosclerotic plaque. Different concentrations of these antigens have been found to coincide with the progression of atherosclerosis. The subject invention also provides different hybridoma cell lines which produce monoclonal antibodies directed to antigens associated with atherosclerosis and a hybridoma cell line which produces monoclonal antibodies directed to antigen associated with normal artery and not with plaque. The atherosclerotic plaque antigen, and monoclonal antibodies made thereto, are used in various methods for detecting in a biological sample an antigen present in, and indicative of the presence of, atherosclerotic plaque. The monoclonal antibodies are also used in methods of imaging atherosclerotic plaque, and treating atherosclerosis. The methods of treating atherosclerosis include a method of digesting atherosclerotic plaque with enzymes, and a method of ablating atherosclerotic plaque using radiation. The subject invention also provides a method of treating atherosclerotic plaque by directly delivering a drug to the plaque. The subject invention further provides a method for treating atherosclerosis by blocking the synthesis of atherosclerotic plaque or by blocking binding of antibodies to the antigen.
REFERENCES:
patent: 4343734 (1982-08-01), Lian et al.
patent: 4628027 (1986-12-01), Gay
patent: 4816567 (1989-03-01), Cabilly et al.
patent: 5026537 (1991-06-01), Daddona et al.
patent: 5110738 (1992-05-01), Takano et al.
patent: 5196324 (1993-03-01), Bumol et al.
Curtiss, L.K. and Witztum, J.L., A Novel Method for Generating Region--Specific Monoclonal Antibodies To Modified Proteins. The Journal Of Clinical Investigation. (Oct. 1983) 72:4 1427-1438.
Haberland, M.E., et al. Malondialdehyde-Altered Protein Occurs In Atheroma Of Watanabe Heritable Hyperlipidemic Rabbits. Science (Jul. 8, 1988) 241: 215-218.
Kimura, J., et al., Monoclonal Antibodies Recognizing Lipid-Laden Cells And Extracellular Regions With Lipid-Deposits In Atherosclerotic Aorta. Virchows Arch. (1986) 410(2): 159-164.
Shih, I.L., et al., Focal Accumulation of An Apolipoprotein B- Based Synthetic Oligopeptide In The Healing Rabbit Arterial Wall. Proc. Nat'l. Acad. Sci. (Feb. 1990) 87: 1436-1440.
Halluin Albert P.
Knode Marian C.
Wortman Donna C.
LandOfFree
Atherosclerotic plaque specific antigens, antibodies thereto, an does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Atherosclerotic plaque specific antigens, antibodies thereto, an, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Atherosclerotic plaque specific antigens, antibodies thereto, an will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1907000